BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Trichostatin A
,
rs2476601
,
EGFR
,
cell-cell adhesion
,
Influenza
,
Retina
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
5-hydroxytryptamine receptor family
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pons
Prefrontal cortex
Dendritic (plasmacytoid) cell
Oral mucosa
Uterus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Obsessive-compulsive disorder
Nerve injury
General adaptation syndrome
Peritoneal foreign body
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
eletriptan
CP 724714
ziprasidone
minaprine
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
GTDC1
PPP2R2C
NR5A1
DMD
NISCH
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for 5-hydroxytryptamine receptor family
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Re…
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Comb…
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT
Post-Operative Nausea and Vomiting in Children Submitted to Strabismus Surgery
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ